Entity

Time filter

Source Type


Amezqueta S.,University of Navarra | Schorr-Galindo S.,Montpellier University | Murillo-Arbizu M.,University of Navarra | Murillo-Arbizu M.,3P Biopharmaceuticals | And 3 more authors.
Food Control | Year: 2012

Ochratoxin A (OTA) is a secondary metabolite produced by filamentous fungi of the genera Aspergillus and Penicillium present in a wide variety of foodstuffs. The most relevant OTA-producing species are Penicillium verrucosum (P. verrucosum), Aspergillus ochraceus (A. ochraceus), Aspergillus niger and Aspergillus carbonarius due to their prevalence in foodstuffs (cereals, grapes, coffee, etc.) and the number of strains able to produce OTA. To target pre- and post-harvest control programs, studies concerning the toxigenic fungi in each foodstuff are essential. This paper summarizes the state-of-the-art and the requirements in OTA control. © 2012 Elsevier Ltd. Source


Trademark
3P Biopharmaceuticals | Date: 2014-10-14

Biopharmaceutical preparations for medical purposes, namely, monoclonal antibodies contained in diagnostic kits for use in disease testing, vaccines and natural biomaterials for augmentation of bone and tissue for medical use; sanitary preparations for medical use; food for babies; nutritional supplements for humans and animals; medical plasters; medical dressings; teeth fillings and dental impression materials; all purpose disinfectants; preparations for destroying vermin; fungicides, herbicides. Research and development of pharmaceutical products and in connection with biotechnology.


3P Biopharmaceuticals | Entity website

Job offer: Logistics Technician Job offer: Logistics Technician The candidate will join the Purchasing and Logistics Department, reporting to the Plant Director. Job assigment: Monitoring and control of the stock to guarantee the supply needed to achieve the manufacturing program as well as minimizing the value of the stock in the warehouse ...


3P Biopharmaceuticals | Entity website

3P Biopharmaceuticals is equipped to handle both New Biological Entities (NBEs) manufacturing (fusion proteins, vaccines, monoclonal antibodies) as well as Biosimilars. Project specific customization of many manufacturing related services such as analytical method development, process validation, stability studies, formulation, advanced therapy services (cell therapy) and Master and Working cell bank generation, characterization and Storage can be offered


3P Biopharmaceuticals | Entity website

3P Biopharmaceuticals is equipped to handle both New Biological Entities (NBEs) manufacturing (fusion proteins, vaccines, monoclonal antibodies) as well as Biosimilars. Project specific customization of many manufacturing related services such as analytical method development, process validation, stability studies, formulation, advanced therapy services (cell therapy) and Master and Working cell bank generation, characterization and Storage can be offered

Discover hidden collaborations